Skip to Main Content

Paper Details

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease.
Prostate
206
1999

Datasets

Release 1.2